New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 20, 2014
07:53 EDTICADiCAD shares recommended following revenue beat at Craig-Hallum
Craig-Hallum continues to recommend iCAD following the better than expected Q4 revenue beat and better than projected eBx placements. Shares are Buy rated with a $13 price target.
News For ICAD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 24, 2015
08:02 EDTICADiCAD's Xoft Brachytherapy System adopted by first hospital in Spain
iCAD announced the first Xoft Axxent Electronic Brachytherapy System in Spain is now available at the Hospital Miguel Servet for the treatment of early-stage breast cancer, non-melanoma skin cancer and gynecological cancers.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use